Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Jennifer A. Wargo
Based on 85 articles published since 2009
(Why 85 articles?)
||||
Expertise Level
The expertise of Jennifer A. Wargo ranks in the
  • Top 0.15%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 85 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Wargo, Jennifer A   ·   Wargo, Jennifer   ·   Wargo, J A   ·   Wargo, J
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2019
  • The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA 19477. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · David Rubenstein Pancreatic Cancer Research Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Pubmed 30635425
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine & Health, Division of Cancer Sciences, The University of Manchester, Manchester, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Astra Zeneca Logistics Centre, Macclesfield, UK. · Pubmed 30277012
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Biomedical Informatics, HMS, Boston, MA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Brigham & Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Virology, Harvard Medical School, Boston, MA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Surgery, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA. Electronic address: · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. Electronic address: · Pubmed 30388456
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 29924973
  • Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Dermatology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Melanoma surgical oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 29672900
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit Number 1484, Houston, TX 77030 USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit Number 1484, Houston, TX 77030 USA. · Pubmed 28239464
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28543700
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Wistar Institute, Molecular and Cellular Oncogenesis Program, Tumor Microenvironment and Metastasis Program, and Melanoma Research Center, Philadelphia, PA, USA. · Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Helen F. Graham Cancer Center at Christiana Care Health System, Newark, DE, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. · Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, NYU School of Medicine, NYU Langone Medical Center, New York, NY, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Pubmed 29141224
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: · Pubmed 29100071
  • Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28803728
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. · Translational Research Institute, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Qld, Australia. · Discipline of Dermatology, University of Sydney, Sydney, NSW, Australia. · Navarrabiomed-Fundación Miguel Servet-Idisna, Pamplona, Spain. · Systems Biology Ireland, School of Medicine, UCD, Dublin 4, Ireland. · Department of Dermatology, Universitätsspital Zürich, University of Zurich, Zurich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK · Pubmed 28606996
  • Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas. · The Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas. · Children's Research Institute and the Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Manchester, United Kingdom. · Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute, University of Sydney, Sydney, New South Wales, Australia. · Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Pubmed 28455392
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine, and Health, School of Medical Sciences, Division of Molecular and Clinical Cancer Studies, The University of Manchester, Manchester M13 9PT, England, UK. · Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, 25123 Brescia, Italy. · Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy. · Division of Oncology, MedImmune Ltd, Cambridge CB21 6GH, England, UK. · Edinburgh Cancer Research Centre, Medical Research Council Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XR, Scotland, UK. · Department of Dermatology, University Hospital Zürich, 8091 Zürich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA 02114. · Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Medical Research Council London Institute of Medical Sciences, London W12 0NN, England, UK. · Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110. · Manchester Cancer Research Centre, Faculty of Biology, Medicine, and Health, School of Medical Sciences, Division of Molecular and Clinical Cancer Studies, The University of Manchester, Manchester M13 9PT, England, UK · Pubmed 28450382
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA. · Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 28442307
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Hematology / Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Head and Neck Surgery, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center. · Department of Pathology, The University of Texas MD Anderson Cancer Center. · Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center. · Pubmed 26991400
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26601872
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27667683
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27458138
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Shenying Fang, Dawen Sui, Yuling Wang, Huey Liu, Yi-Ju Chiang, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Jennifer Wargo, Mimi I. Hu, Julie M. Gardner, Roland L. Bassett, and Jeffrey E. Lee, The University of Texas MD Anderson Cancer Center · John D. Reveille, The University of Texas Health Science Center at Houston, Houston, TX · Qingyi Wei, Duke University School of Medicine, Durham, NC · and Christopher I. Amos, Dartmouth College, Lebanon, NH. · Pubmed 27001565
  • Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. · Molecular Oncology Group, CRUK Manchester Institute for Cancer Research, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4BX, UK. · Department of Dermatology, UniversitätsSpital Zürich, University of Zürich, Gloriastrasse 31, 8091 Zurich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114-2696, USA. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. Electronic address: · Pubmed 26977879
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America. · Division of Dermatopathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 26461489
  • The Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Surgery, MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medicine, Massachusetts General Hospital, Boston, Massachussetts, USA. · The Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · The Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA; The Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26302068
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Pubmed 26058727
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Massachusetts General Hospital, Harvard Medical School, Cambridge, MA 02114, USA. · Department of Dermatology, University Hospital of Zürich and University of Zürich, 8091 Zürich, Switzerland. · Departments of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, PA 19104, USA. · Weizmann Institute, Rehovot 76100, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, Yale School of Medicine, New Haven, CT 06520, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 26027934
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26025561
  • Wellman Center for Photomedicine/Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. · MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. · Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Wellman Center for Photomedicine/Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: · Pubmed 25789707
  • Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Eli and Edythe L. Broad Institute of Massachusetts, Institute of Technology and Harvard University, Cambridge, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25754356
  • Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. Department of Dermatology, Harvard Medical School, Boston, Massachusetts. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts. · Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. Department of Dermatology, Harvard Medical School, Boston, Massachusetts. MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Pubmed 25542448
2014
  • Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Pubmed 24983357
  • Department of Pharmacology and Cancer Biology, Duke University, 450 Research Drive, Durham, NC 27710, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA. · University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA. · Department of Pharmacology and Cancer Biology, Duke University, 450 Research Drive, Durham, NC 27710, USA. · Pubmed 25538079
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · MD Anderson Cancer Center, Houston, Texas. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Pubmed 25319388
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Manchester Cancer Research Centre, Wellcome Trust Center for Cell Matrix Research, Faculty of Life Sciences, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. · Division of Cancer Biology, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, SW3 6JB, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK. · Department of Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA, USA. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25256614
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; and. · 3M Drug Delivery Systems Division, 3M Company, St. Paul, MN 55144. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Pubmed 25252955
  • Authors' Affiliations: Departments of Surgical Oncology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; · Harvard-MIT Division of Health Sciences and Technology, Cambridge; Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of. · Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of. · Medical Oncology. · Harvard Medical School; Divisions of Dermatopathology, and. · Harvard Medical School; Divisions of. · Harvard Medical School; Divisions of Department of Medical Oncology, Dana-Farber Cancer Institute; · Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; · Helen Diller Family Comprehensive Cancer Center; and Department of Cell and Molecular Pharmacology, University of California San Francisco, San Francisco, California. · Harvard Medical School; Divisions of Medical Oncology. · Harvard Medical School; Divisions of Dermatology, Massachusetts General Hospital; · Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; · Authors' Affiliations: Departments of Surgical Oncology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; · Pubmed 24903021
  • Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; Department of Medical Oncology, Dana-Farber Cancer Institute; Divisions of. · Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; · Surgical Oncology, and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Dermatopathology and. · Surgical Oncology. · Massachusetts General Hospital Cancer Center, and Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts; Departments of. · Massachusetts General Hospital Cancer Center, and. · Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; Department of Medical Oncology, Dana-Farber Cancer Institute; Divisions of · Pubmed 24771846
2013
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
2012
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
Probable:    Universite Paris-Saclay      
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
Probable:    Institut Gustave Roussy      
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 85 total) written by Jennifer A. Wargo about Melanoma:

  • Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. 2019
  • A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF 2019
  • Combination Immunotherapy Development in Melanoma. 2018
  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. 2018
  • Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. 2018
  • Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. 2018
  • Immune Checkpoint Blockade across the Cancer Care Continuum. 2018
  • Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall. 2018
  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. 2018
  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. 2018
Show List of Full Article Records
Google Searches

Learn more about Jennifer A. Wargo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Universite Paris-Saclay
Institut Gustave Roussy
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2019
  • The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA 19477. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · David Rubenstein Pancreatic Cancer Research Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Pubmed 30635425
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine & Health, Division of Cancer Sciences, The University of Manchester, Manchester, UK. · Division of Molecular Pathology, The Institute of Cancer Research, London, UK. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Astra Zeneca Logistics Centre, Macclesfield, UK. · Pubmed 30277012
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Biomedical Informatics, HMS, Boston, MA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Brigham & Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA. · Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Virology, Harvard Medical School, Boston, MA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Surgery, Massachusetts General Hospital, HMS, Boston, MA, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, HMS, Boston, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA. Electronic address: · Massachusetts General Hospital Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Medicine, Massachusetts General Hospital, HMS, Boston, MA, USA. Electronic address: · Pubmed 30388456
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: · Pubmed 29924973
  • Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Dermatology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Melanoma surgical oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 29672900
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit Number 1484, Houston, TX 77030 USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit Number 1484, Houston, TX 77030 USA. · Pubmed 28239464
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28543700
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Wistar Institute, Molecular and Cellular Oncogenesis Program, Tumor Microenvironment and Metastasis Program, and Melanoma Research Center, Philadelphia, PA, USA. · Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Helen F. Graham Cancer Center at Christiana Care Health System, Newark, DE, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. · Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, NYU School of Medicine, NYU Langone Medical Center, New York, NY, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Pubmed 29141224
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: · Pubmed 29100071
  • Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 28803728
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. · Translational Research Institute, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Qld, Australia. · Discipline of Dermatology, University of Sydney, Sydney, NSW, Australia. · Navarrabiomed-Fundación Miguel Servet-Idisna, Pamplona, Spain. · Systems Biology Ireland, School of Medicine, UCD, Dublin 4, Ireland. · Department of Dermatology, Universitätsspital Zürich, University of Zurich, Zurich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK · Pubmed 28606996
  • Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas. · The Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas. · Children's Research Institute and the Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Manchester, United Kingdom. · Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute, University of Sydney, Sydney, New South Wales, Australia. · Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Pubmed 28455392
  • Manchester Cancer Research Centre, Faculty of Biology, Medicine, and Health, School of Medical Sciences, Division of Molecular and Clinical Cancer Studies, The University of Manchester, Manchester M13 9PT, England, UK. · Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, 25123 Brescia, Italy. · Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy. · Division of Oncology, MedImmune Ltd, Cambridge CB21 6GH, England, UK. · Edinburgh Cancer Research Centre, Medical Research Council Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XR, Scotland, UK. · Department of Dermatology, University Hospital Zürich, 8091 Zürich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA 02114. · Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Medical Research Council London Institute of Medical Sciences, London W12 0NN, England, UK. · Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110. · Manchester Cancer Research Centre, Faculty of Biology, Medicine, and Health, School of Medical Sciences, Division of Molecular and Clinical Cancer Studies, The University of Manchester, Manchester M13 9PT, England, UK · Pubmed 28450382
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA. · Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 28442307
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Hematology / Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Head and Neck Surgery, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center. · Department of Pathology, The University of Texas MD Anderson Cancer Center. · Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center. · Pubmed 26991400
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26601872
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27667683
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27458138
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Shenying Fang, Dawen Sui, Yuling Wang, Huey Liu, Yi-Ju Chiang, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Jennifer Wargo, Mimi I. Hu, Julie M. Gardner, Roland L. Bassett, and Jeffrey E. Lee, The University of Texas MD Anderson Cancer Center · John D. Reveille, The University of Texas Health Science Center at Houston, Houston, TX · Qingyi Wei, Duke University School of Medicine, Durham, NC · and Christopher I. Amos, Dartmouth College, Lebanon, NH. · Pubmed 27001565
  • Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. · Molecular Oncology Group, CRUK Manchester Institute for Cancer Research, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4BX, UK. · Department of Dermatology, UniversitätsSpital Zürich, University of Zürich, Gloriastrasse 31, 8091 Zurich, Switzerland. · Department of Medicine, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114-2696, USA. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. Electronic address: · Pubmed 26977879
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America. · Division of Dermatopathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 26461489
  • The Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Surgery, MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medicine, Massachusetts General Hospital, Boston, Massachussetts, USA. · The Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · The Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA; The Department of Cutaneous Oncology, The Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26302068
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Pubmed 26058727
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Massachusetts General Hospital, Harvard Medical School, Cambridge, MA 02114, USA. · Department of Dermatology, University Hospital of Zürich and University of Zürich, 8091 Zürich, Switzerland. · Departments of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, PA 19104, USA. · Weizmann Institute, Rehovot 76100, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, Yale School of Medicine, New Haven, CT 06520, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 26027934
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26025561
  • Wellman Center for Photomedicine/Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. · MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. · Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Wellman Center for Photomedicine/Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: · Pubmed 25789707
  • Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Eli and Edythe L. Broad Institute of Massachusetts, Institute of Technology and Harvard University, Cambridge, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25754356
  • Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. Department of Dermatology, Harvard Medical School, Boston, Massachusetts. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts. · Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. Department of Dermatology, Harvard Medical School, Boston, Massachusetts. MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Pubmed 25542448
2014
  • Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Pubmed 24983357
  • Department of Pharmacology and Cancer Biology, Duke University, 450 Research Drive, Durham, NC 27710, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA. · University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. · Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA. · Department of Pharmacology and Cancer Biology, Duke University, 450 Research Drive, Durham, NC 27710, USA. · Pubmed 25538079
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · MD Anderson Cancer Center, Houston, Texas. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Pubmed 25319388
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Manchester Cancer Research Centre, Wellcome Trust Center for Cell Matrix Research, Faculty of Life Sciences, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. · Division of Cancer Biology, The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, SW3 6JB, UK. · Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK. · Department of Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA, USA. · Divison of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25256614
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; and. · 3M Drug Delivery Systems Division, 3M Company, St. Paul, MN 55144. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Pubmed 25252955
  • Authors' Affiliations: Departments of Surgical Oncology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; · Harvard-MIT Division of Health Sciences and Technology, Cambridge; Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of. · Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of. · Medical Oncology. · Harvard Medical School; Divisions of Dermatopathology, and. · Harvard Medical School; Divisions of. · Harvard Medical School; Divisions of Department of Medical Oncology, Dana-Farber Cancer Institute; · Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; · Helen Diller Family Comprehensive Cancer Center; and Department of Cell and Molecular Pharmacology, University of California San Francisco, San Francisco, California. · Harvard Medical School; Divisions of Medical Oncology. · Harvard Medical School; Divisions of Dermatology, Massachusetts General Hospital; · Department of Microbiology and Immunobiology; Harvard Medical School; Divisions of Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; · Authors' Affiliations: Departments of Surgical Oncology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; · Pubmed 24903021
  • Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; Department of Medical Oncology, Dana-Farber Cancer Institute; Divisions of. · Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; · Surgical Oncology, and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Dermatopathology and. · Surgical Oncology. · Massachusetts General Hospital Cancer Center, and Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts; Departments of. · Massachusetts General Hospital Cancer Center, and. · Authors' Affiliations:Broad Institute of Harvard and MIT, Cambridge; Department of Medical Oncology, Dana-Farber Cancer Institute; Divisions of · Pubmed 24771846
2013
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
2012
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
Universite Paris-Saclay
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
Institut Gustave Roussy
2018
  • From the Gustave Roussy Cancer Institute and University Paris-Saclay, Villejuif, France; Earle A. Chiles Research Institute, Portland, OR; The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 30231333
Harvard University Boston
2017
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts. · Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of Surgical Oncology, Massachusetts General Hospital, Charlestown, Massachusetts. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · Pubmed 28446504
  • Department of Radiology, Massachusetts General Hospital, Boston, MA 02114. · Center for Systems Biology, Massachusetts General Hospital, Boston, MA 02114. · Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA 02114. · Pubmed 27993725
2016
  • The First Bethune Hospital and Institute of Immunology, Jilin University, Changchun, China. · Columbia Center for Translational Immunology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 26824989
  • Department of Molecular Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Proteomics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Biostatistics and Bioinformatics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 26073081
2009
  • Department of Surgery, Harvard Medical School, Boston, MA, USA. · Pubmed 19464603
2014
  • 1Department of Medical Oncology, Dana-Farber Cancer Institute; 2Department of Medicine, Brigham and Women's Hospital; 3Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT; and 5Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts. · Pubmed 24265154
  • Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA. · Pubmed 24732172
2013
  • Department of Medicine, Massachusetts General Hospital, Boston, USA. · Pubmed 23841733
  • Massachusetts General Hospital, Harvard Medical School, Boston, MA. · Pubmed 24238058
  • 1] The Broad Institute of Harvard University and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA [2] Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA [3] Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts 02115, USA. · Pubmed 24185007
  • 1Tumor Metastasis and Microenvironment Program and 2Molecular and Cellular Oncogenesis Program, The Wistar Institute; 3Abramson Cancer Center, University of Pennsylvania, Philadelphia; 4Lehigh Valley Health Network, Allentown, Pennsylvania; 5The National Institute on Aging, NIH, Baltimore, Maryland; and 6Dana-Farber/Harvard Cancer Center, Boston, Massachusetts. · Pubmed 24104062
  • Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA. · Pubmed 23903755
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. · Pubmed 23477830
  • Division of Medical Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02115, USA. · Pubmed 23447565
  • Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. · Pubmed 23307859
  • Genetics Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02115, USA. · Pubmed 23171796
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23095323
2012
  • Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. · Pubmed 23123854
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 22983396
  • The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. · Pubmed 22817889
  • The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Pubmed 22622578
2010
  • Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 21109158
  • Broad Institute of Harvard and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA. · Pubmed 21107320
  • Division of Surgical Oncology, Medical Oncology, and Dermatology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. · Pubmed 20551059
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 19744448
7 Other Locations Show
Yearly article counts 281516910116251
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.